This is unpublished

Stephanie J.
Lee
M.D.
M.P.H.

Stephanie J. Lee

Fred Hutchinson Cancer Center

1100 Fairview Ave. N, D5-290 

Seattle, WA 98109 

Physician & Research Faculty
Pinned
Academic
Professor and Associate Director, Clinical Research Division, Fred Hutchinson Cancer Center
David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research, Fred Hutch
Professor, Division of Hematology and Oncology, University of Washington
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union
UW Medical Center - Montlake

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.D., Stanford University 
  • M.P.H., Harvard School of Public Health 
  • Internship and Residency, Stanford University 
  • Fellowship, Brigham and Women’s Hospital and Harvard University 
  • Hematology, American Board of Internal Medicine

Clinical Expertise    

  • Hematopoietic stem cell transplantation 
  • Survivorship and quality of life
  • Long term follow-up 
  • Graft-vs.-host disease

Affiliations  

Publications

PubMed
 

Research and/or clinical interests 

Dr. Stephanie Lee is a hematologist and blood and marrow transplant physician-scientist who treats patients with leukemia, lymphoma and other blood and bone marrow diseases. Her research aims to improve the lives of bone marrow and blood stem cell transplant recipients. She leads a nationwide research network that focuses on improving the understanding of chronic graft-vs.-host disease, or GVHD, and the best ways to prevent, diagnose and treat it. In this common, long-term and sometimes life-threatening transplant complication, donor immune cells attack the recipient’s body. Dr. Lee is especially interested in the chronic form of GVHD, which causes symptoms ranging from painful dry eye and mouth to skin thickening, lung problems and susceptibility to infections. She also studies many other transplant-related topics, including survivorship and patient-reported outcomes. She serves as research director of Fred Hutch’s Long-Term Follow-Up Program, which tracks the outcomes of more than 6,500 transplant survivors.